Stock Events

Stock Events

Biondvax Pharmaceuticals 

$1.3600
17
+$0.05+3.82% Wednesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
25.4M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

2MayExpected
Q3 2021
Q4 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2023
-2.7
-1.8
-0.89
0.01
Expected EPS
-0.1
Actual EPS
0

Financials

-Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
0Revenue
1.72MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Biological Product (except Diagnostic) Manufacturing
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. The company is developing the M-001 Universal Flu Vaccine. M-001 is undergoing a pivotal, clinical efficacy, Phase 3 trial in about 12,400 participants. M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic. In 6 completed clinical trials the vaccine was shown to be safe, well tolerated and immunogenic to a broad range of flu strains. The Company’s technology utilizes a proprietary combination of conserved and common peptides from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect.
Show more...
CEO
Ron Babecoff
Employees
25
Country
United States
ISIN
US09073Q1058
WKN
000A3DZ0C

Listings

MU
DE
2F5.MU
STU
DE
2F5.STU
F
DE
2F5.F
BOATS
BOATS
SCNI.BOATS

0 Comments

Share your thoughts

FAQ

What is Biondvax Pharmaceuticals stock price today?▼
The current price of BVXV is $1.36 USD — it has increased by +3.82% in the past 24 hours. Watch Biondvax Pharmaceuticals stock price performance more closely on the chart.
What is Biondvax Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Biondvax Pharmaceuticals stocks are traded under the ticker BVXV.
What is Biondvax Pharmaceuticals market cap?▼
Today Biondvax Pharmaceuticals has the market capitalization of 25.4M
What were Biondvax Pharmaceuticals earnings last quarter?▼
BVXV earnings for the last quarter are 0 USD per share, whereas the estimation was -0.1 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biondvax Pharmaceuticals revenue for the last year?▼
Biondvax Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Biondvax Pharmaceuticals net income for the last year?▼
BVXV net income for the last year is 1.72M USD.
How many employees does Biondvax Pharmaceuticals have?▼
As of July 24, 2026, the company has 25 employees.
In which sector is Biondvax Pharmaceuticals located?▼
Biondvax Pharmaceuticals operates in the Manufacturing sector.
When did Biondvax Pharmaceuticals complete a stock split?▼
The last stock split for Biondvax Pharmaceuticals was on November 25, 2022 with a ratio of 1:10.
Where is Biondvax Pharmaceuticals headquartered?▼
Biondvax Pharmaceuticals is headquartered in Po Box 4143 14 Einstein Street, United States.